http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a93be4341dd2b29e51a14289f4d6a4b4
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Blasco |
| name | Maria A Blasco Maria A. Blasco |
| given-name | Maria A Maria A. |
| organization-name | Authors' Affiliation: Spanish National Cancer Research Center (CNIO), Molecular Oncology Program, Telomere and Telomerase Group, Madrid, Spain Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid 28029, Spain Telomeres and Telomerase Group Spanish National Cancer Research Centre (CNIO) Madrid Spain Department of Immunology and Oncology, National Centre of Biotechnology E‐28049 Madrid Spain Telomeres and Telomerase Group; Molecular Oncology Program; Spanish National Cancer Centre (CNIO); Madrid, Spain Department of Immunology and Oncology, Centro Nacional de Biotecnologia-CSIC, Campus Cantoblanco, E-28049 Madrid, Spain Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain Molecular Oncology Program Telomeres and Telomerase Group Spanish National Cancer Research Centre (CNIO) Madrid E‐28029Spain Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), 28029 Madrid, Spain Spanish National Cancer Center, Madrid, Spain Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Research Centre, 28029 Madrid, Spain Telomeres and Telomerase Group Spanish National Cancer Centre (CNIO) Madrid Spain Telomeres and Telomerase Group Molecular Oncology Program Spanish National Cancer Centre (CNIO) Melchor Fernández Almagro 3 E‐28029 Madrid Spain Telomere and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain Telomeres and Telomerase Group Molecular Oncology Program Spanish National Cancer Research Centre (CNIO) Madrid Spain Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre, 28029 Madrid, Spain Telomeres and Telomerase Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain Telomeres and Telomerase Group, Molecular Oncology Program, and Telomeres and Telomerase Group Spanish National Cancer Research Centre Madrid Spain From INSERM U955, DHU A-TVB and Département de Physiologie, Hôpital Henri Mondor, Créteil, France and Université Paris-Est Créteil, France (N.M., A.H., S.A., E.M., A.P., G.G.-B., G.D., J.B., L.L., V.A., S.A.); Respiratory Division, University Hospitals of Leuven and Department of Clinical and Experimental Medicine, University of Leuven, Leuven, Belgium (R.Q., M.D.); Service de Cardiologie, Hôpital Henri Mondor and Université Paris-Est Créteil, Créteil, France (J.-L.D.-R.); and Spanish National... Telomeres and Telomerase Group, Molecular Oncology Programme, CNIO-Spanish National Cancer Research Center, Madrid, Spain Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid E-28029, Spain Telomere and Telomerase Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid 28029, Spain; Telomeres and Telomerase Group; Molecular Oncology Program; Spanish National Cancer Centre (CNIO); Melchor Fernández Almagro 3 Madrid E-28029 Spain Telomeres and Telomerase Group, Molecular Oncology Programme, Spanish National Cancer Research Centre, E-28029 Madrid, Spain 1 Telomeres and Telomerase Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro, 3, 28029 Madrid, Spain Telomeres and Telomerase Group 1 and 2; Tumor Suppression Group, Molecular Oncology Program, Spanish National Cancer Centre, Madrid E-28029, Spain 1 and 2 Department of Obstetrics and Gynecology, Brown Medical School, Women and Infants Hospital, Providence, RI 02905; Laboratory for Reproductive Medicine, Marine Biological Laboratory, Woods Hole, MA 02543; Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre, 28029 Madrid, Spain; and Department of Biology, York University, North York, ON, Canada M3J 1P3 Telomeres and Telomerase Group Molecular Oncology Program Spanish National Cancer Research Centre (CNIO) Melchor Fernández Almagro 3 Madrid E‐28029 Spain From the Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. Spanish National Cancer Research Centre (CNIO), 3 Melchor Fernandez Almagro, 28029, Madrid, Spain. 2Telomeres and Telomerase Group, Molecular Oncology Programme, Spanish National Cancer Center, Madrid 28029, Spain Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Center, Madrid, E-28029, Spain Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Research Center, 3 Melchor Fernandez Almagro, E-28029, Madrid, Spain Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, E-28029, Spain Laboratoire de Chimie de Coordination, CNRS, 205 route de Narbonne, 31077 Toulouse Cedex 4, France, INSERM IFR 31, Institut Louis Bugnard, Hôpital Rangueil, TSA 50032, 31059 Toulouse Cedex 9, France, Spanish National Cancer Center, Melchor Fernández Almagro 3, 28029 Madrid, Spain, INSERM U 531, Institut Louis Bugnard, Hôpital Rangueil, TSA 50032, 31059 Toulouse Cedex 9, France, and Palumed, BP 28262, 31682 Labège Cedex, France Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Melchor Fernández Almagro 3, Madrid, Spain From the Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. Telomeres and Telomerase Group Molecular Oncology Program Spanish National Cancer Centre (CNIO) Melchor Fernández Almagro 3 Madrid E‐28029 Spain Telomeres and Telomerase Group 1 and 2 and 3; Genomic Instability Group, Molecular Oncology Programme 1 and 2 and 3; Molecular Imaging Core Unit, Biotechnology Programme, Spanish National Cancer Centre, Madrid 28029, Spain 1 and 2 and 3 Department of Immunology and Oncology, National Centre of Biotechnology, Spanish Council for Scientific Research (CSIC), Campus de Cantoblanco, Madrid E-28049, Spain. Telomeres and Telomerase Group, CNIO, Madrid E28029, Spain. Telomere and Telomerase Group, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO), Madrid E-28029, Spain Telomeres and Telomerase Group, Spanish National Cancer Research Centre (CNIO); Madrid Spain Telomeres and Telomerase Group, Molecular Oncology Program and Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Research Centre, 28029 Madrid, Spain; |
Incoming Links
Total number of triples: 199.